|
1
|
Guo K, Pan Q, Wang L and Fang S:
Nano-scale copper-coated graphite as anode material for lithium-ion
batteries. J Appl Electrochem. 32:679–685. 2002. View Article : Google Scholar
|
|
2
|
Liu G, Li X, Qin B, Xing D, Guo Y and Fan
R: Investigation of the mending effect and mechanism of copper
nano-particles on a tribologically stressed surface. Tribol Lett.
17:961–966. 2004. View Article : Google Scholar
|
|
3
|
Cioffi N, Ditaranto N, Torsi L, Picca RA,
Sabbatini L, Valentini A, Novello L, Tantillo G, Bleve-Zacheo T and
Zambonin PG: Analytical characterization of bioactive fluoropolymer
ultra-thin coatings modified by copper nanoparticles. Anal Bioanal
Chem. 381:607–616. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lei R, Wu C, Yang B, Ma H, Shi C, Wang Q,
Wang Q, Yuan Y and Liao M: Integrated metabolomic analysis of the
nano-sized copper particle-induced hepatotoxicity and
nephrotoxicity in rats: A rapid in vivo screening method for
nanotoxicity. Toxicol Appl Pharmacol. 232:292–301. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Magdassi S, Grouchko M and Kamyshny A:
Copper nanoparticles for printed electronics: Routes towards
achieving oxidation stability. Materials (Basel). 3:4626–4638.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoon KY, Hoon ByeonJ, Park JH and Hwang J:
Susceptibility constants of Escherichia coli and Bacillus
subtilis to silver and copper nanoparticles. Sci Total Environ.
373:572–575. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee IC, Ko JW, Park SH, Lim JO, Shin IS,
Moon C, Kim SH, Heo JD and Kim JC: Comparative toxicity and
biodistribution of copper nanoparticles and cupric ions in rats.
Int J Nanomedicine. 11:2883–2900. 2016.PubMed/NCBI
|
|
8
|
Chen Z, Meng H, Xing G, Chen C, Zhao Y,
Jia G, Wang T, Yuan H, Ye C, Zhao F, et al: Acute toxicological
effects of copper nanoparticles in vivo. Toxicol Lett. 163:109–120.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sarkar A, Das J, Manna P and Sil PC:
Nano-copper induces oxidative stress and apoptosis in kidney via
both extrinsic and intrinsic pathways. Toxicology. 290:208–217.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guengerich FP: Human Cytochrome P450
Enzymes. Cytochrome P450: Structure, Mechanism, and Biochemistry.
Ortiz de Montellano PR: Springer International Publishing; Cham:
pp. 523–785. 2015
|
|
11
|
Backman JT, Filppula AM, Niemi M and
Neuvonen PJ: Role of cytochrome P450 2C8 in drug metabolism and
interactions. Pharmacol Rev. 68:168–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hedlund E, Gustafsson JA and Warner M:
Cytochrome P450 in the brain; a review. Curr Drug Metab. 2:245–263.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miksys S and Tyndale RF: Cytochrome
P450-mediated drug metabolism in the brain. J Psychiatry Neurosci.
38:152–163. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Toselli F, Dodd PR and Gillam EM: Emerging
roles for brain drug-metabolizing cytochrome P450 enzymes in
neuropsychiatric conditions and responses to drugs. Drug Metab Rev.
48:379–404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Li J, Dong G and Yue J: The
endogenous substrates of brain CYP2D. Eur J Pharmacol. 724:211–218.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schilter B, Andersen MR, Acharya C and
Omiecinski CJ: Activation of cytochrome P450 gene expression in the
rat brain by phenobarbital-like inducers. J Pharmacol Exp Ther.
294:916–922. 2000.PubMed/NCBI
|
|
17
|
Huang P, Rannug A, Ahlbom E, Håkansson H
and Ceccatelli S: Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on
the expression of cytochrome P450 1A1, the aryl hydrocarbon
receptor, and the aryl hydrocarbon receptor nuclear translocator in
rat brain and pituitary. Toxicol Appl Pharmacol. 169:159–167. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sánchez-Catalán MJ, Hipólito L, Guerri C,
Granero L and Polache A: Distribution and differential induction of
CYP2E1 by ethanol and acetone in the mesocorticolimbic system of
rat. Alcohol Alcohol. 43:401–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miksys SL and Tyndale RF:
Drug-metabolizing cytochrome P450s in the brain. J Psychiatry
Neurosci. 27:406–415. 2002.PubMed/NCBI
|
|
20
|
Hedlund E, Wyss A, Kainu T, Backlund M,
Köhler C, Pelto-Huikko M, Gustafsson JA and Warner M: Cytochrome
P4502D4 in the brain: Specific neuronal regulation by clozapine and
toluene. Mol Pharmacol. 50:342–350. 1996.PubMed/NCBI
|
|
21
|
Mann A, Miksys S, Lee A, Mash DC and
Tyndale RF: Induction of the drug metabolizing enzyme CYP2D in
monkey brain by chronic nicotine treatment. Neuropharmacology.
55:1147–1155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Strobel HW, Thompson CM and Antonovic L:
Cytochromes P450 in brain: Function and significance. Curr Drug
Metab. 2:199–214. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Funae Y, Kishimoto W, Cho T, Niwa T and
Hiroi T: CYP2D in the brain. Drug Metab Pharmacokinet. 18:337–349.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ferguson CS and Tyndale RF: Cytochrome
P450 enzymes in the brain: Emerging evidence of biological
significance. Trends Pharmacol Sci. 32:708–714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bai R, Zhang L, Liu Y, Li B, Wang L, Wang
P, Autrup H, Beer C and Chen C: Integrated analytical techniques
with high sensitivity for studying brain translocation and
potential impairment induced by intranasally instilled copper
nanoparticles. Toxicol Lett. 226:70–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao M and Liu H: Gene expression
profiling of nephrotoxicity from copper nanoparticles in rats after
repeated oral administration. Environ Toxicol Pharmacol. 34:67–80.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sarkar P, Narayanan J and Harder DR:
Differential effect of amyloid β on the cytochrome P450 epoxygenase
activity in rat brain. Neuroscience. 194:241–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Auyeung DJ, Kessler FK and Ritter JK: An
alternative promoter contributes to tissue-and inducer-specific
expression of the rat UDP-glucuronosyltransferase 1A6 gene. Toxicol
Appl Pharmacol. 174:60–68. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daniel WA, Haduch A, Syrek M and Boksa J:
Direct and indirect interactions between antidepressant drugs and
CYP2C6 in the rat liver during long-term treatment. Eur
Neuropsychopharmacol. 16:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Haduch A, Wójcikowski J and Daniel WA: The
effect of tricyclic antidepressants, selective serotonin reuptake
inhibitors (SSRIs) and newer antidepressant drugs on the activity
and level of rat CYP3A. Eur Neuropsychopharmacol. 16:178–186. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meyer RP, Gehlhaus M, Knoth R and Volk B:
Expression and function of cytochrome p450 in brain drug
metabolism. Curr Drug Metab. 8:297–306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Navarro-Mabarak C, Camacho-Carranza R and
Espinosa-Aguirre JJ: Cytochrome P450 in the central nervous system
as a therapeutic target in neurodegenerative diseases. Drug Metab
Rev. 50:95–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang L, Bai R, Liu Y, Meng L, Li B, Wang
L, Xu L, Le Guyader L and Chen C: The dose-dependent toxicological
effects and potential perturbation on the neurotransmitter
secretion in brain following intranasal instillation of copper
nanoparticles. Nanotoxicology. 6:562–575. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kakehashi A, Hagiwara A, Imai N, Nagano K,
Nishimaki F, Banton M, Wei M, Fukushima S and Wanibuchi H: Mode of
action of ethyl tertiary-butyl ether hepatotumorigenicity in the
rat: Evidence for a role of oxidative stress via activation of CAR,
PXR and PPAR signaling pathways. Toxicol Appl Pharmacol.
273:390–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tolson AH and Wang H: Regulation of
drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv
Drug Deliv Rev. 62:1238–1249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Waxman DJ: P450 gene induction by
structurally diverse xenochemicals: Central role of nuclear
receptors CAR, PXR, and PPAR. Arch Biochem Biophys. 369:11–23.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Deres P, Halmosi R, Toth A, Kovacs K,
Palfi A, Habon T, Czopf L, Kalai T, Hideg K, Sumegi B and Toth K:
Prevention of doxorubicin-induced acute cardiotoxicity by an
experimental antioxidant compound. J Cardiovasc Pharmacol.
45:36–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xu P, Xu J, Liu S, Ren G and Yang Z: In
vitro toxicity of nanosized copper particles in PC12 cells induced
by oxidative stress. J Nanopart Res. 14:9062012. View Article : Google Scholar
|
|
40
|
Xu P, Xu J, Liu S and Yang Z: Nano copper
induced apoptosis in podocytes via increasing oxidative stress. J
Hazard Mater. 241-242:279–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thannickal VJ and Fanburg BL: Reactive
oxygen species in cell signaling. Am J Physiol Lung Cell Mol
Physiol. 279:L1005–L1028. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martindale JL and Holbrook NJ: Cellular
response to oxidative stress: Signaling for suicide and survival. J
Cell Physiol. 192:1–15. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yoshida Y, Itoh N, Saito Y, Hayakawa M and
Niki E: Application of water-soluble radical initiator, 2,2′-azobis
[2-(2-imidazolin-2-yl) propane] dihydrochloride, to a study of
oxidative stress. Free Radic Res. 38:375–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yadav S, Dhawan A, Singh RL, Seth PK and
Parmar D: Expression of constitutive and inducible cytochrome P450
2E1 in rat brain. Mol Cell Biochem. 286:171–180. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Roberts BJ, Shoaf SE, Jeong KS and Song
BJ: Induction of CYP2E1 in liver, kidney, brain and intestine
during chronic ethanol administration and withdrawal: Evidence that
CYP2E1 possesses a rapid phase half-life of 6 hours or less.
Biochem Biophys Res Commun. 205:1064–1071. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Joshi M and Tyndale RF: Induction and
recovery time course of rat brain CYP2E1 after nicotine treatment.
Drug Metab Dispos. 34:647–652. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Miksys S, Wadji FB, Tolledo EC, Remington
G, Nobrega JN and Tyndale RF: Rat brain CYP2D enzymatic metabolism
alters acute and chronic haloperidol side-effects by different
mechanisms. Prog Neuropsychopharmacol Biol Psychiatry. 78:140–148.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ramsden CS, Smith TJ, Shaw BJ and Handy
RD: Dietary exposure to titanium dioxide nanoparticles in rainbow
trout, (Oncorhynchus mykiss): No effect on growth, but subtle
biochemical disturbances in the brain. Ecotoxicology. 18:939–951.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Aleksunes LM and Klaassen CD: Coordinated
regulation of hepatic phase I and II drug-metabolizing genes and
transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice.
Drug Metab Dispos. 40:1366–1379. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Thompson EE, Kuttab-Boulos H, Krasowski MD
and Di Rienzo A: Functional constraints on the constitutive
androstane receptor inferred from human sequence variation and
cross-species comparisons. Hum Genomics. 2:168–178. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tien ES and Negishi M: Nuclear receptors
CAR and PXR in the regulation of hepatic metabolism. Xenobiotica.
36:1152–1163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fradette C, Yamaguchi N and Du Souich P:
5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to
hydroxylamine, which is converted into nitric oxide. Br J
Pharmacol. 141:407–414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bromek E, Haduch A, Gołembiowska K and
Daniel WA: Cytochrome P450 mediates dopamine formation in the brain
in vivo. J Neurochem. 118:806–815. 2011. View Article : Google Scholar : PubMed/NCBI
|
